Company: MVNC
Filing Date: 2025-01-10
Form Type: PRE 14C
Source: 0001683168-25-000215
Chunk: 1

Company: Marvion Inc.
Filing Date: 2025-01-10
Form: PRE 14C
Chunk 1
---
 Olayinka Oyebola & Co as our independent registered public accounting firm                                  
 for the fiscal year ending December 31, 2024;                                                                                         
 To approve the adoption of the Marvion Inc. 2023 Stock Incentive Plan (the “2023 Plan”).                                              |
|:---|:--------------------------------------------------------------------------------------------------------------------------------------|
| 4. | To approve an amendment to the 2023 Plan (the “2023 Plan Amendment”) as adopted by the Board                                          
 on December 28, 2024. The 2023 Plan Amendment relates to an increase in the number of shares of Common Stock of the Company remaining 
 for issuance under the 2023 Plan by 31,408,394 shares of Common Stock.                                                                |
| 5. | To consider and act on an advisory (non-binding) proposal on the compensation arrangements of certain                                 
 executive officers; and                                                                                                               |
| 6. | To consider and act on an advisory (non-binding) proposal on how frequently stockholders should vote to                               
 approve the compensation arrangements of certain executive officers.                                                                  |

This notice and accompanying Information Statement shall constitute notice to you of the Voting Stockholders taking the Corporate Actions by written consent, without a meeting, pursuant to the requirements of the NRS.

The accompanying Information Statement is being provided
to you for your information to comply with the requirements of Regulation 14C of the Securities Exchange Act of 1934, (“Exchange
Act”). This Information Statement constitutes notice to you of the Corporate Actions taken without a meeting, pursuant to the requirements
of the NRS. You are urged to read this Information Statement carefully in its entirety. However, no action is required on your part in connection with this document, including with respect to the approval of the 2023 Plan and the Plan Amendment. No meeting of our
stockholders will be held or proxies requested because we have received written consent to these matters from the Voting Stockholders.

Under Rule 14c-2(b) of the Exchange Act, none of the
actions described in the Information Statement may be taken earlier than 20 calendar days after we have sent or given the Information
Statement to our stockholders. We intend to distribute this Notice and Information Statement to our stockholders on or about ____ ___,
2025. The record date established for purposes of determining the number of issued and outstanding shares of voting stock, and thus voting
power, was December 28, 2024.

THIS IS FOR YOUR INFORMATION ONLY. YOU DO NOT NEED TO